As a core element in the molecular machinery of selective autophagy, this far more detailed insight into the membrane docking steps of LC3 will undoubtedly facilitate the therapeutic targeting of autophagy in Parkinson’s disease and other neurodegenerative diseases. The gene discussed is MAP1LC3A; the disease is Parkinson disease.